Now showing items 1-3 of 3

    • Anti-miRNA Delivery Systems Based on Self-assembled Nanostructure 

      Zhang, Yu (2016-02-17)
      Nanomedicine has been one of the focuses of drug delivery field, especially when it comes to cancer therapy, due to the unprecedented potential benefits it could bring, such as specificity and high cargo loading. Standing ...
    • Going Past the Data for Temozolomide 

      Villano, J. Lee; Letarte, Nathalie; Bressler, Linda R. (Springer Verlag, 2012-04)
      The benefit of six cycles of adjuvant temozolomide was documented in a randomized phase III (EORTC‐NCIC CE.3) trial and this therapy, following combined temozolomide and radiation, is the standard of care for patients ...
    • Localized targeted antiangiogenic drug delivery for glioblastoma 

      Arnone, Gregory, D.; Bhimani, Abhiraj, D.; Aguilar, Tania; Mehta, Ankit, I. (Elsevier, 2018-01-11)
      Systemic delivery of antiangiogenic agents has been ineffective in improving the overall survival of patients with both primary and recurrent glioblastoma, in part due to dose-limiting toxicities. With the development of ...